Clinical Trials Browser

Phase 2 × Interventional × Darbepoetin alfa × Clear all

NCT00146562 2023-08-02

Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00058422 2020-11-12

Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma

Phase 2 Completed

65 enrolled 9 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT02890602 2020-02-20

Erythropoietin for Management of Anemia Caused by Chemotherapy

Phase 2 Completed

Lymphoma, Large B-Cell, Diffuse

NCT00416624 2017-02-10

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Phase 2 Completed

239 enrolled 23 charts

Classical hematologyDermatologicLymphoidOther hematologic neoplasmOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Anemia, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Leukemia, Mast-Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Mycosis Fungoides, Precancerous Conditions, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

NCT00077311 2016-06-30

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

Classical hematologyThoracic

Adenocarcinoma of Lung, Anemia, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutropenia, Drug-Related Side Effects and Adverse Reactions

NCT00401544 2014-01-29

Darbepoetin Alfa With or Without Intravenous (IV) Iron

Phase 2 Completed

243 enrolled 26 charts

Classical hematology

Anemia, Neoplasms

NCT00989092 2014-01-29

Darbepoetin Alfa and Anemia of Cancer

Phase 2 Terminated

287 enrolled 21 charts

Classical hematology

Anemia, Carcinoma, Neoplasms

NCT00386152 2013-07-19

A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy

Phase 2 Terminated

235 enrolled 13 charts

Classical hematology

Anemia, Neoplasms

NCT00144131 2013-05-24

Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy

Phase 2 Completed

Classical hematology

Anemia, Neoplasms

NCT00111462 2013-05-08

Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy

Phase 2 Completed

Classical hematology

Anemia, Neoplasms

NCT00540696 2013-04-26

Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa

Phase 2 Completed

Classical hematology

Anemia

NCT00359840 2012-08-31

A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor

Phase 2 Completed

Classical hematology

Anemia

NCT00239239 2010-03-05

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

Phase 2 Completed

Classical hematology

Anemia, Neoplasms

NCT00261313 2010-02-26

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00036023 2009-05-11

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Phase 2 Completed

BreastLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00120705 2009-03-25

Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy

Phase 2 Completed

Classical hematology

Anemia, Neoplasms

NCT00095277 2009-03-13

Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer

Phase 2 Completed

Classical hematologyPlasma cell

Anemia, Neoplasms, Plasma Cell

NCT00120679 2007-12-24

Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy

Phase 2 Completed

Classical hematologyThoracic

Anemia, Carcinoma, Non-Small-Cell Lung

NCT00120692 2007-12-24

Treatment for Patients Suffering From Anemia Due to Chemotherapy

Phase 2 Completed

BreastClassical hematology

Anemia, Breast Neoplasms

NCT00121030 2007-12-24

Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy

Phase 2 Completed

Classical hematologyGynecologic

Anemia, Genital Neoplasms, Female, Ovarian Neoplasms, Uterine Neoplasms

NCT00245895 2007-11-29

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

Phase 2 Completed

Classical hematologyGenitourinary

Anemia, Prostatic Neoplasms

NCT00210002 2006-11-14

Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced

Phase 2 Terminated

Classical hematology

Anemia, Neoplasms

NCT00039884 2005-06-24

Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?

Phase 2 Unknown

Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms